Cortotic contains hydrocortisone aceponate (HCA), a diester glucocorticosteroid to reduce inflammation.
In a clinical field study, published in Veterinary Dermatology, Cortotic was shown to be as effective in treating acute otitis as a fixed-combination product containing a corticosteroid, an antibiotic and an antifungal, with an equivalent improvement of clinical and cytological scores1.
A secondary reduction of bacterial and yeast overgrowth was demonstrated and a concomitant treatment with an antimicrobial was unnecessary.
The product was shown to provide rapid relief from clinical signs, pruritus and pain1.
Virbac says the lipophilic nature of the HCA diester provides enhanced penetration into the skin, a reservoir effect and low plasma availability for high local activity with reduced systemic secondary effects2.
Chris Newark, Product Manager at Virbac said: "With Cortotic we’re excited to offer clinicians the ability to reduce antimicrobial usage when treating otitis externa in dogs, whilst offering the same efficacy as a fixed-combination product.
"The product’s easy administration also makes it an attractive choice for pet owners with 94% of owners stating that they would choose to use Cortotic again3".
Cortotic is presented in an ear spray device with atraumatic cannula, which delivers a fine mist spray for even application.
Dosing is 2 pumps per application, whatever the dog’s size, once a day for 7-14 days.
References
The posters are designed to educate clients about what their pet should be drinking on a daily basis, according to their weight.
The company has also prepared a rehydration social media pack with content for practices to use on their social media feeds.
Posters can be requested and social media packs downloaded at: https://www.animalcare.co.uk/oralade-poster.
The new app has been specifically developed for CVS, is unique to the group, and is owned by the company.
It is powered by LocumBell technology.
When registering on the app, locums can input their work preferences - including their skills, desired travel radius and preferred shift times - so that they are only served up shift advertisements relevant to them.
Users can also set up notifications for upcoming jobs.
The app then allows locums to set minimum shift rates, submit the rate they would like to receive for a shift and negotiate their fees directly with a practice.
Shifts can be then be booked or cancelled on the app at the touch of a button.
All upcoming booked shifts appear on the users’ calendar.
Once a shift has been completed, locums can submit the invoice for their work using the app.
The app allows locums to see every CVS practice invoice and its status, which CVS says will allow queries to be resolved quicker and payments issued faster.
The app is being rolled out to all of CVS's practices from this August.
Amy Hughes, Head of Recruitment at CVS, said: “Locum administration can be time-consuming – as locums first have to identify work, liaise with a practice and our central support team, to negotiate and book a shift, then complete all invoice paperwork.
"We wanted to remove that pain and make it easier for locums to work with us.
The app is available for Apple devices on the App Store and for Android devices on the Play Store.
For any technical difficulties or assistance, contact: support@locumbell.com or call 0161 556 7685.
There had already been a gap in supply of the vaccine between June and August due to a batch being out of specification.
The company says it submitted an Out of Specification request to release the vaccine but was unsuccessful.
The next delivery of vaccine was expected at the end of August, however this has unfortunately been delayed until October, and there is no certainty of this delivery.
Ceva says it deeply regrets the inconvenience caused to sheep farmers this year.
Roy Geary, Vice President for Northern Europe (including the UK) at Ceva Animal Health, said: “The manufacturing of vaccines is a complex process that involves stringent quality control measures and adherence to regulatory guidelines.
"There have been unforeseen manufacturing issues at our production facilities, which have temporarily affected the ability to meet the demands of the UK sheep market within the main seasonal vaccination period for EAE.
"As a responsible provider, we are actively addressing these issues to minimise the impact on customers.”
“We are recommending that vets and farmers follow the advice published on 24th July 2024 from the Sheep Vet Society and Sheep Antibiotic Guardian Group (SAGG).”
https://sheepvetsoc.org.uk/news/sheep-veterinary-society-svs-and-sheep-antibiotic-guardian-group-sagg-advice-for-when-an-enzootic-abortion-eae-vaccine-is-unavailable.
Dr Radev faced three charges concerning his treatment of an American Bulldog in 2021.
The first charge, which contained a number of sub-charges, was that he failed to provide appropriate and adequate care to the animal.
The second was that he failed to keep adequate records.
The final charge was that his failure to keep records was misleading and dishonest.
At the outset of the hearing Dr Radev admitted that, having recognised free fluid in the dog’s abdomen, he failed to take adequate and appropriate action and failed to aspirate the dog’s abdomen with regards to the possibility of it having septic peritonitis.
He also admitted writing the clinical notes approximately two months after the event.
After considering and rejecting an application by the RCVS to amend and withdraw elements of the first charge, the Committee then considered each of the remaining sub-charges in turn.
Sub-charge 1(a) was that Dr Radev repeatedly administered meloxicam to the dog when it had recently undergone intestinal surgery and had a recent history of vomiting.
The Committee found that this was not proven.
Dr Radev said it had been administered just once and the Committee was not satisfied so as to be sure that it was repeatedly administered.
Sub-charge 1(b) (i) was that Dr Radev failed to recognise free fluid in the dog’s abdomen as shown on an ultrasound scan.
The Committee found this not proven.
Sub-charge 1(c) (i) was that Dr Radev failed to recognise the possibility of septic peritonitis in the dog.
Sub-charge 1(e) was that Dr Radev failed to provide a full medical history when referring the dog to a different practice.
The Committee found the charge not proven.
Regarding charge 2 (ii), that Dr Radev had failed to include in clinical records a reference to the colonotomy surgery, the Committee found this charge not proven as it had been provided with clinical records disproving this charge.
Finally, regarding both aspects of charge 3, namely that Dr Radev had acted misleadingly and dishonesty, the Committee found this not proven.
The Committee then considered whether the charges that Dr Radev had admitted amounted to gross misconduct in a professional respect.
In all cases it found that, while Dr Radev’s conduct had fallen below what was expected of veterinary professionals, it did not fall so far below as to constitute serious professional misconduct.
www.rcvs.org.uk/disciplinary
The survey of 2067 past or present adult dog owners, of which 1,170 had experienced the loss of a dog, also found that about half had experienced barriers to opening up about their feelings following the death of their pet.
Some of the reasons given for not opening up included believing others wouldn’t understand their feelings (22%), fear of being judged for being upset (15%), feeling embarrassed about their levels of distress (12%) and not being able to find the right words to describe their feelings (13%).
74% felt they could turn to close family to share feelings of grief over the loss of the dog, but only 13% felt they could discuss it with employers and colleagues.
Samantha Davis, Legacy and In-Memory Manager at Dogs Trust, says: “The loss of a pet dog can be as devastating as losing a family member.
"Dogs hold a special place in our hearts, offering unconditional love and companionship, and when they pass away, the grief can be profound and, sadly for some, isolating.
“It's really important that owners who experience the loss of their canine companions can open up and share their feelings with friends and family.
"Many will find solace in knowing they are not alone."
To support people who have lost a dog, Dogs Trust is holding a 3.5km walk to bring people together to share their memories of their beloved animal.
Walk for Our Old Friends (WOOF) will take place in Salcey Forest, Northampton, on Sunday 6th October 2024 between 4pm-7pm.
As walkers make their way through the forest, there will be opportunities for moments of remembrance and celebration.
The charity will also provide support resources for those participating with a team onsite as well as online information to help people cope with their loss.
Dogs Trust is also providing online resources for people to organise their own walk in memory of their much missed four legged friends.
https://events.dogstrust.org.uk/event/walk-for-our-old-friends
COMMENT
Was this survey desperately flawed, or has our relationship with our dogs become unhealthily anthropomorphic?
It's hard to think of any other explanation for why such large proportion of people equate the death of a dog with the death of a brother, sister, parent or child.
Surely the death of a close family member is in an altogether different league than the death of even the most beloved dog.
If people are developing unhealthily close relationships with their animals, the question is why?
Are they being pushed by commercial interests which encourage people to think of themselves as 'pet parents' in order that they feel compelled to spend more on their 'child'.
Or is there some other factor in play?
Does it matter anyway?
Perhaps not.
But more and more we hear stories of people saddling themselves with crippling levels of debt on treatment because they cannot face the inevitable.
Perhaps it is time to return to a more healthy, more matter-of-fact relationship with our pets.
No less loving, just tempered by the acceptance of the fact that it is not human. It's a dog.
In the online survey of 392 dog owners, which was conducted Companion Consultancy, 64.5% of owners said their dog has suffered from gastrointestinal upset.
51.8% said they used home cooked chicken and rice to manage their dog's digestive upset.
28.6% sought veterinary advice.
18.8% used a pre and probiotic, despite half of the respondents thinking they would be useful.
Veterinary nurse and sales manager at Vita, Tara Evans, said: “We know that digestive upset is very common in dogs, and almost two thirds of the survey respondents identified that scavenging was the primary cause of upset.
"We want to help support pet owners in knowing how they can best look after their pet in these situations, and provide them with both educational resources and an effective product.
“Education is key in helping owners make the best choices for their dogs.
"Changing their diet in a time of digestive upset isn’t always the best option, so it’s important that we provide owners with up-to-date information."
www.vitaanimalhealth.com
The opening speaker will be Cassie Leonard (pictured), engineer, best-selling author and executive coach, who will be talking about the value of authentic networking.
The programme, which includes a combination of lectures, panel sessions and interactive workshops, will cover:
On the Saturday, there's a dedicated ‘Grow your business’ day for those thinking of starting up or expanding their business.
New for 2025 will be a Friday morning collaborative ‘Business Club Live’ speed-networking session: an opportunity to discuss a variety of issues on hosted tables.
Also new for 2025 will be a dedicated livestock stream focussing on the unique challenges faced by livestock veterinary professionals.
The accompanying exhibition will host a selection of companies focussed on the business, management, marketing and client-facing aspects of veterinary practice and offering the latest products, services and advice.
Social events include Thursday afternoon's Happy Hour followed by a networking event and Friday night’s Presidents’ party with a reception, 3-course meal and a performance by the party band The Kings.
www.spvs-congress.co.uk
The guides have been developed for vet teams to share with their clients and work through together, so that both sides are on the same page about owner values, pet welfare and behaviour, and diagnosis and treatment options.
A member of the veterinary team and the client can then work together to make decisions and provide quality care.
One of the pet owners who helped develop the guides said: “I always get so worked up with vet consultations that I forget half of what they say, or feel like I didn’t tell them enough about my pet’s history.
"If the vet used these guides at my next consult, they would make me feel very at ease indeed!”
Pam Mosedale, Clinical Lead at RCVS Knowledge, said: “These guides offer a simple, actionable way to help deliver contextualised care in practice.
"To get started, run through the questions in the guide with a client, and see how this can help you devise a treatment plan with the information you’ve discovered.
"This helps you gain a fuller understanding of your patient’s care and wellbeing needs and your client’s circumstances and expectations.
"Ultimately, this will assist you in delivering quality care that aligns with the needs and expectations of your clients.”
There are three contextualised care discussion guides:
RCVS Knowledge is encouraging veterinary teams to adapt the guides to meet their individual needs.
https://rcvsknowledge.org/contextualisedcare
Anything which helps clear communication between the owner and vet is surely to be applauded, and if owners are prepared to spend the time completing the pre-consultation guide, it would surely leave less room for error.
However, arguably the greatest cause of friction between owners and vets is cost, and that is something only mentioned fleetingly, in the context of: 'Are there any other factors that may impact on the care of your pet? e.g planned holidays or financial concerns'.
Isn't it time to stop beating around the bush?
Isn't there an opportunity here for greater clarity over the level of spending a client is happy with?
Is there an acceptable form of words here to ascertain whether - regardless of whether they have financial concerns or not - the client is one of those who wants the cheapest solution to the problem, one for whom money is no object, or someone who sits somewhere in the middle?
Wouldn't that be more instructive than almost anything else?
DISCUSS HERE
Virbac highlights research which shows that 90% of all dogs over one year are affected by dental issues, including plaque, tartar, gingivitis and halitosis1, but small breed dogs are 5 times more likely to have dental issues than large breeds2.
The new formulation of Veterinary HPM Small & Toy range contains Ascophyllum Nodosum, which Virbac says has been scientifically proven activity on four aspects of oral and dental health: calculus index, volatile sulphur compound concentration, plaque index and gingival bleeding index3.
Virbac points to research which shows that after being absorbed in the small intestine and then secreted into the oral cavity via saliva, Ascophyllum Nodosum inhibits some pathways involved in plaque or calculus development4.
Nutrition-wise, Virbac says the new diet offers 33% less carbohydrate and 34% more protein, on average, compared to other brands sold in veterinary practices5.
90% of the protein included in the diets is also from animal protein.
The updated range also features 2 new kibble sizes (10.5mm & 7.5mm), for smaller mouths.
Rosemullion Veterinary Practice is a three-site small animal practice owned by CVS.
It has 100 members of staff and dispenses 3,584 medications in an average month.
According to an article in Companion Animal, medication errors account for 30% of all reported errors in veterinary practice1.
Errors can be prescribing errors - where the vet prescribes the incorrect medication or dosage, or dispensing errors where the incorrect medication, strength or volume is dispensed by the pharmacy team.
Some errors can ‘look or sound alike’ – where medications have similar names or packaging – making them easy to mix up.
Rosemullion conducted an initial clinical audit of entries on its VetSafe system between 1st March and 31st May 2023.
Analysis was conducted on the drugs involved, whether they were prescribing or dispensing errors or near misses, and looking for patterns of behaviour or the drugs involved.
During this time there were 29 (0.27%) near misses and 14 (0.13%) errors.
Prescribing near misses most often involved flea and worm products.
Here additional feedback from vets was that it was difficult to remember weight brackets for all products and when weight brackets were included in the drug description this made them easier to prescribe accurately.
As a consequence, the Rosemullion pharmacy team introduced the inclusion of weight brackets on all flea and worm products.
Dispensing errors and near misses were mostly related to ‘look or sound alike’, particularly in worming tablets, flea treatments and Rheumocam cat and dog.
To address this, the Rosemullion pharmacy team added extra labelling to dispensary draws and separated draws for flea and worm treatments into different weight brackets.
Rheumocam – with its similar packaging design and box sizes – was also split into separate cat and dog drawers, and drawers clearly labelled up with the version and volume to make dispensing clearer.
Feedback was also given to the drug manufacturer.
Rosemullion also held a CPD session to highlight the common errors that were occurring, to explain resulting process and systems improvements, and ask the team to take extra care with these dispensaries.
A new ‘handing out medication’ process was also created – involving checking the medication in the bag matched the on the screen notes, confirming it was for the correct animal and validating it was what the owner was expecting.
A subsequent audit was run from 1st October to 31st November 2023.
The results revealed there were no prescribing or dispensing errors (0%) and only 8 (0.13%) near misses during this time.
Alice Bell, Senior Vet and Quality Improvement Lead at Rosemullion Veterinary Practice, said: “We place patient safety at the forefront of all we do.
"We wanted to conduct this extensive audit to assess our prescribing and dispensing processes and systems.
“The methods we had in place made it easy to do the task correctly and the changes we have now put in place have made the process even safer for our clients.
"Our overall error and near miss is now at a really low number compared to our total number of medication dispenses.
“The teams have been very receptive to the improvements and the project has had a positive impact on various aspects of the practice, including on team wellbeing.”
Rosemullion Veterinary Practice’s initiative has recently been recognised with a RCVS Knowledge Highly Commended status at its 2024 awards.
Reference
The session is designed for business owners who are considering succession planning and who may be interested in exploring alternative ownership structures.
Speakers include Jeff Lermer from JLA Accountants and Victoria Dorman from HCRLaw, both of whom have helped companies transition to employee ownership.
Matt Flann from Pennards Vets (pictured) will add the perspective of a business that has transitioned to being an Employee Owned Trust.
The session will cover the structure of Employee Ownership Trusts, the benefits of transitioning (including tax incentives) and the legal, financial and operational considerations.
The webinar was also offer practical guidance on the steps and timelines for implementing an EOT in your organization.
https://spvs.org.uk/employee-ownership-trusts-cpd
The new resources include:
Celia Marr, chair of BEVA’s infectious disease working group, said: “Equine disease prevention and management are fundamental for responsible equine health, welfare and performance.
“These resources cover the need-to-know information and are all in one easy reverence location on the newly designed infection control page on the BEVA website.”
https://www.beva.org.uk/Resources/Equine-infectious-diseases
Vetlife's campaign included talks at various veterinary events, an awareness video, a series of lived experience blogs, and a downloadable resource for individuals and workplaces, all made possible by grant funding from the Zoetis Foundation.
Kirstie Pickles, Vetlife Trustee and project lead for the neurodiversity campaign said: “To be shortlisted was an honour, but to win this award is just incredible and is a testament to the dedication and passion that the team put into the campaign.
"It has been a pleasure and a privilege to lead this project and share this much needed information with the veterinary community.
"It is our hope that this campaign and its resources will enable and initiate discussions within teams to ensure that all within our wonderful veterinary professions can thrive."
https://www.vetlife.org.uk
According to the NFU, last year farm animals worth an estimated £2.4 million pounds were severely injured or killed by dog attacks last year.
Obtaining forensic samples after an attack can be difficult because so often they happen in remote places and rural police can't always attend quickly enough to get a sample.
Dr. Nick Dawnay from Liverpool John Moores University therefore developed Early Evidence Kits to enable samples to be collected by vets, famers and police from the crime scene immediately.
Following a successful proof of concept in Wales, the research team is now trialling the kits in ten regions of England and Wales, with support from IVC Evidensia farm practices.
Over the next twelve months the trial will refine best practices for collecting forensic samples from livestock attack scenes.
David Martin, Group Head of Animal Welfare at IVC Evidensia said: “This project marks an exciting step forward in collecting and analysing canine DNA from livestock.
"It offers police and farmers a means to hold irresponsible dog owners culpable for the damage and losses caused by their pets.”
“As a profession we can support this research by ensuring samples are taken from as many cases within the relevant force areas as possible so that the team at John Moores gets sufficient material to be able to complete this project as soon as possible.
"All IVC Evidensia farm practices in the participating regions are being encouraged to use the kits and we want to ensure all farm practices in those regions know about this important project.”
It is hoped new legislation for England and Wales will be brought in to give police officers the power to take a DNA sample from a suspected dog to compare to canine DNA left at an attack scene.
Dave Allen, North Wales Police and NPCC Livestock Offence Working Group Secretary said: “These kits are an exciting development and can be utilised for an issue that causes major concern to our UK rural communities”.
Veterinary practices are now being encouraged help raise awareness of the project, particularly to encourage farmers to take part and use the kits to collect evidence in the following regions:
https://www.ljmu.ac.uk/about-us/news/articles/2024/5/17/forensic-science-to-help-farmers-foil-sheep-attacks
Bluevac-3 is an inactivated injectable vaccine indicated for the active immunisation against BTV-3 for use in sheep and cattle.
Ceva says it reduces viraemia, prevents mortality and reduces the clinical signs of BTV-3 in sheep and reduces viraemia in cattle.
In sheep, Bluevac-3 can be administered from two months of age and two doses of 2ml should be administered subcutaneously three weeks apart.
In cattle, the vaccine can be administered from two months of age and two doses of 4ml should be administered three weeks apart.
Onset of immunity occurs 21 days/three weeks after completion of primary vaccination in cattle and sheep.
The vaccine can be used in pregnancy in cows and ewes.
No negative impact on milk-yield after using the vaccine in lactating ewes and cows is expected.
Ceva developed the new vaccine in partnership with vaccine manufacturer CZV Vaccines and launched it in Europe early in the summer, to mitigate the impact of the disease already experienced in the Netherlands, Belgium, and Germany.
Craig Wright, ruminant business unit director at Ceva Animal Health, said: “In co-operation with our partner, CZV Vaccines, we have worked tirelessly to bring Bluevac-3 to the UK to help fight bluetongue which has the potential to cause severe financial loss to farmers.
"The availability of an effective vaccine is an essential tool to help suppress future outbreaks by reducing viraemia, preventing mortality and reducing the clinical signs of BTV-3.”
Licences to allow the use of the new vaccine will either be geographically targeted general licences, initially in high risk counties as part of a phased approach, or specific licences which can be applied for through APHA.
General licencing will be subject to risk assessment.
https://www.gov.uk/government/publications/summary-of-product-characteristics-for-bluevac-3-btv-3-vaccine-in-the-uk.
The announcement came hot on the heels of announcements from Ceva and Boehringer that they too had vaccines in the pipeline.
Syvazul BTV3 is licensed to reduce viraemia, prevent mortality and reduce clinical signs and lesions in sheep and for the active immunisation against bluetongue virus serotype 3 in cattle.
Like all vaccines currently available for this serotype, the vaccine will not prevent infection and vaccinated animals will still be subject to bluetongue movement controls and trade restrictions currently in place.
Administered as a single 2ml dose subcutaneously in sheep and as two 4ml intramuscular doses 3 weeks apart in cattle, Syvazul BTV3 contains inactivated Bluetongue virus, serotype 3 (BTV-3), strain BTV-3/NET2023.
The vaccine is licenced for use during pregnancy and lactation in both sheep and cattle.
The onset of immunity is 28 days after the primary vaccine in sheep. A single booster revaccination dose of 2ml for sheep and 4ml for cattle is recommended after 12 months.
Presented in two pack sizes, 80ml and 200ml, Syvazul BTV3 vaccine has a shelf life of 2 years from manufacture and a broach life of 10 hours.
Licensing for use will be geographic, based upon high risk counties or by specific licence from the APHA.
Furosoral contains furosemide and is indicated for the treatment of hydrothorax, hydropericardium, ascites and oedema, particularly in animals where these conditions are associated with cardiac insufficiency and renal dysfunction.
Furosoral replaces Dechra’s previous diuretic treatment, Frusedale.
It is available in both 10 mg and 40 mg double-divisable tablets.
The recommended daily starting dose for cats and dogs is 2.5 mg per kg of body weight.
Dechra says careful weighing is essential to ensure accurate dosing, but that the dosage can be doubled initially for severe or particularly resistant cases and adjusted to the lowest clinically effective dose for maintenance therapy if required.
Dechra companion animal brand manager, Charlotte Hill, said: “Furosoral offers a flexible treatment solution where dosage can be adjusted, depending on the needs of the patient and the underlying causes, to give vets more options for treating cats and dogs with fluid retention.
“To ensure it is as appealing to pet owners as it is to veterinary professionals, Furosoral is available in our innovative Smart Tab format, giving owners confidence that they are giving their dog or cat the right dosage and aiding compliance, leading to better outcomes for the animal.”
Furosoral 10 mg and 40 mg tablets are available in blister packs of 100 tablets for quick and easy dispensing. Divided tablets can be stored in the blister pack for up to three days, ensuring no waste.
https://www.dechra.co.uk/products/dog/prescription#/search=furosoral/.
The webinar will cover the entire disease process of MMVD in dogs from pathology to current treatment approaches and future advancements in therapy, and will include the following presentations:
https://us06web.zoom.us/webinar/register/WN_QyfUofLgRG-YsaXQbkT7Tw#/registration
Francesca's initiative was recognised with a RCVS Knowledge ‘Highly Commended’ status at its 2024 awards.
The idea for the audit came about after Francesca noticed a trend for patients to become hypotensive during anaesthesia for routine feline neutering and need additional treatment.
CVS says clinical evidence suggests a minimum value of 60mmHg for perfusion of vital organs such as the brain, heart and kidneys.
So a clinical audit was undertaken to look at perioperative blood pressure in both cats and dogs having routine neutering procedures.
The target was for patients to maintain a mean arterial blood pressure of 60mmHg during their anaesthetic.
The animals chosen for auditing were to be classed ASA 1 and under 5 years old.
They received a pre-operative health check including a blood pressure reading to ensure they were normotensive.
A first audit looked at a standard premedication protocol of ACP at a dose rate of 0.02mg/kg combined with methadone at a dose rate of 0.3mg/kg.
A second audit initiated a change to the pre-medication drugs, using 0.005mg/kg medetomidine combined with the same dose of methadone.
Both received anaesthesia induction with Propoflo at a dose rate of 6mg/kg for cats and 4mg/kg for dogs.
All patients under anaesthetic were maintained using isoflurane and kept at a surgical plane of anaesthesia appropriate for that patient.
The patients were monitored throughout their surgical procedure using an oscilliometric monitoring machine - for systolic, diastolic and mean arterial blood pressure – and measurements recorded on an anaesthetic chart.
The collected data revealed that in the first audit, where patients received ACP and methadone, 42% (50% of cats and 38% of dogs) had a mean arterial blood pressure lower than 60mmHg after the first five blood pressure readings post induction.
In the second audit, with medetomidine combined with methadone, only 11% of patients (0% of cats and 15% of dogs) with a mean arterial blood pressure lower than 60mmHg.
In addition to the reduction in hypotensive patients during anaesthesia when the medetomidine/methadone combo was used, Francesca says the audit suggests a link to hypotension with ACP used as a premedication in anaesthetised patients.
Francesca said: “My passion in veterinary nursing is anaesthesia. And there is always room for improvement and striving to achieve gold standard care.
“These results clearly show that a change from our current premedication protocol of ACP and Methodone to Medetomidine and Methadone decreased the number of patients having hypotension during anaesthesia. The change means fewer patients were at risk of developing the side effects associated with hypoperfusion of the vital organs.
“Our quality improvement initiative has made a really positive impact in practice for both patient care and clinical team.”
In the study: "Effects of human-animal interaction on salivary and urinary oxytocin in children and dogs1", oxytocin levels were recorded in 55 children and their pet dogs.
Oxytocin is associated with positive emotions, the reduction of stress and the formation of social bonds.
Oxytocin levels were tracked in both the children’s and dogs’ urine and saliva before and after they interacted.
Researchers say this is one of the first studies to examine the benefits of human animal interactions for both humans and dogs.
For the study, the children's oxytocin levels were measured when they interacted with their own pet dog, with an unfamiliar dog (a trained therapy dog), and when they engaged in solitary play.
The study found that:
The researchers concluded that the results support the hypothesis that oxytocin pathways may shape and respond to social interactions between children and dogs, highlighting an important role for companion animals in child development.
https://www.waltham.com/oxytocin-children-and-dogs
The materials include pet owner guides, reception posters and slides to display on waiting room TV.
They complement the Krka veterinary professional guide on responsible risk-based parasiticide use for cats and dogs that was developed in conjunction with Ian Wright BVMS MSc MRCVS and launched last year.
Renzo Di Florio, Krka’s Technical Veterinary Adviser said: “In first opinion veterinary practice, where the majority of consultations last 15 minutes or less, time is short and in-depth discussions are not always possible.
"The guides provide comprehensive information on common parasites, practical advice on prevention and treatment and information on risk assessment.
"And by aligning with ESCCAP guidelines, the guides help address the delicate balance between animal health, human health and environmental protection – a true One Health issue.”
https://www.krka.co.uk/veterinary-knowledge-hub/articles/risk-based-parasiticide-use-for-cats-and-dogs
Zoetis says the Vetscan OptiCell represents a significant leap forward in technology and offers meaningful time, cost and space savings for veterinary healthcare teams, contributing to better patient outcomes and a more efficient clinic workflow.
It uses cell-focusing and AI-powered classification technology for CBC analysis, delivering a claimed lab quality accuracy at the point of care.
Dr. Richard Goldstein, DVM, DACVIM, DECVIM-CA, Global Chief Medical Officer and Head of Medical Affairs at Zoetis said: “Vetscan OptiCell delivers high-quality results, enables improved efficiency, and provides a compact footprint.
"For the first time, we are able to use advanced AI image recognition technology to characterise the blood cells instead of relying on their size or other physical parameters.”
Pre-orders will be available in the UK later this year.
The awards fall into two categories, those which you need to be nominated for by other people and those which are also open to self-nomination:
Requiring nomination by another person:
Self-nominations allowed:
The deadline for the 2025 awards is Friday, 13 December 2024.
https://www.rcvs.org.uk/how-we-work/rcvs-honours-awards
The films, which include information and practical advice based on the pillars of lifestyle medicine and the neuropsychology of hormones, are aimed both at individuals who are directly affected and those who want to support them.
Wellvet co-founder Liz Barton said: “We now know that nearly half of veterinary team members experience a moderate-severe impact of perimenopause symptoms on their mental health, and a third report a significant impact on their working life and career."
Dr. Claire Gillvray, GP, Lifestyle Medicine specialist and psychiatrist with a special interest in women’s health, who introduces the films, said: “While we tend to focus on the individual, we all have friends, family, colleagues and clients who will experience symptoms impacting their mental and physical health and relationships.
"Although some women transition through the menopause with no problems, many women suffer a multiplicity of debilitating symptoms.
"These symptoms can be devastating and the medical advice they receive can be extremely variable, with some doctors dismissing perimenopause.
"Though onset can be earlier, symptoms typically occur between the ages of 40-60 years and can last for a decade or more, and there can be severe health impacts including cardiovascular, neurological and orthopaedic disease."
“These videos will empower individuals to take control of their symptom monitoring, have meaningful conversations with medical professionals, and trial lifestyle adjustments that may improve their health and wellbeing.”
The first instalment of nine 5-30 minute bitesize videos are accessible now on the WellVet website: https://www.wellvet.co.uk/resources/menopause-resources-for-veterinary-teams/.